Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of XP12B in Women With Menorrhagia

ClinicalTrials.gov ID: NCT00401193

Public ClinicalTrials.gov record NCT00401193. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 2:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study To Evaluate Efficacy and Safety of XP12B for the Treatment of Menorrhagia

Study identification

NCT ID
NCT00401193
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ferring Pharmaceuticals
Industry
Enrollment
304 participants

Conditions and interventions

Interventions

  • Tranexamic acid tablets Drug
  • Placebo tablets Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 49 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2006
Primary completion
Apr 30, 2008
Completion
Apr 30, 2008
Last update posted
May 12, 2015

2006 – 2008

United States locations

U.S. sites
83
U.S. states
35
U.S. cities
79
Facility City State ZIP Site status
Investigative Site Birmingham Alabama 35209
Investigative Site Phoenix Arizona 85015
Investigative Site Tucson Arizona 85710
Investigative Site Tucson Arizona 85712
Investigative Site Little Rock Arkansas 72205
Investigative Site Searcy Arkansas 72143
Investigative Site Los Alamitos California 90720
Investigative Site Los Angeles California 90027
Investigative Site San Diego California 92108
Investigative Site Denver Colorado 80202
Investigative Site Groton Connecticut 06340
Investigative Site Gainesville Florida 32610
Investigative Site Jacksonville Florida 32216
Investigative Site Lighthouse PT Florida 33064
Investigative Site Miami Florida 33186
Investigative Site Miami Beach Florida 33141
Investigative Site New Port Richey Florida 34652
Investigative Site Sarasota Florida 34233
Investigative Site Atlanta Georgia 30328
Investigative Site Decatur Georgia 30033
Investigative Site Boise Idaho 83712
Investigative Site Idaho Falls Idaho 83404
Investigative Site Bloomington Indiana 47403
Investigative Site Newton Kansas 67114
Investigative Site Overland Park Kansas 66215
Investigative Site Marrero Louisiana 70072
Investigative Site Baltimore Maryland 21230
Investigative Site Ann Arbor Michigan 48106
Investigative Site Bingham Farms Michigan 48025
Investigative Site Grand Rapids Michigan 49506
Investigative Site Paw Paw Michigan 49079
Investigative Site Saint Clair Shores Michigan 48081
Investigative Site Kansas City Missouri 64114
Investigative Site Missoula Montana 59808
Investigative Site McCook Nebraska 69001
Investigative Site Las Vegas Nevada 89128
Investigative Site Lawrenceville New Jersey 08648
Investigative Site Moorestown New Jersey 08057
Investigative Site New Brunswick New Jersey 08903
Investigative Site Albuquerque New Mexico 87131
Investigative Site New York New York 10017
Investigative Site Rochester New York 14621
Investigative Site Durham North Carolina 27713
Investigative Site Raleigh North Carolina 27607
Investigative Site Winston-Salem North Carolina 27103
Investigative Site Bismarck North Dakota 58501
Investigative Site Cleveland Ohio 44121
Investigative Site Cleveland Ohio 44122
Investigative Site Gallipolis Ohio 45631
Investigative Site Zanesville Ohio 43701
Investigative Site Oklahoma City Oklahoma 73104
Investigative Site Oklahoma City Oklahoma 73112
Investigative Site Eugene Oregon 97401
Investigative Site Portland Oregon 97205
Investigative Site Levittown Pennsylvania 19056
Investigative Site Philadelphia Pennsylvania 19104
Investigative Site Philadelphia Pennsylvania 19114
Investigative Site Phoenixville Pennsylvania 19460
Investigative Site Strafford Pennsylvania 19087
Investigative Site Wexford Pennsylvania 15090
Investigative Site Wynnewood Pennsylvania 19096
Investigative Site Greenville South Carolina 29605
Investigative Site Sioux Falls South Dakota 57104
Investigative Site Bristol Tennessee 37620
Investigative Site Clarksville Tennessee 37043
Investigative Site Nashville Tennessee 37203
Investigative Site Austin Texas 78737
Investigative Site Bryan Texas 77802
Investigative Site Fort Worth Texas 76132
Investigative Site Houston Texas 77030
Investigative Site Plano Texas 75093
Investigative Site Temple Texas 46502
Investigative Site The Woodlands Texas 77380
Investigative Site Waco Texas 76712
Investigative Site Webster Texas 77598
Investigative Site Pleasant Grove Utah 84062
Investigative Site Salt Lake City Utah 84124
Investigative Site West Jordan Utah 84088
Investigative Site West Valley City Utah 84120
Investigative Site Burlington Vermont 05401
Investigative Site Norfolk Virginia 23502
Investigative Site Richmond Virginia 23225
Investigative Site Renton Washington 98055

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00401193, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 12, 2015 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00401193 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →